Chemoinformaics analysis of 1-Monolinolenoyl-rac-glycerol
| Molecular Weight | 352.515 | nRot | 16 |
| Heavy Atom Molecular Weight | 316.227 | nRig | 4 |
| Exact Molecular Weight | 352.261 | nRing | 0 |
| Solubility: LogS | -3.351 | nHRing | 0 |
| Solubility: LogP | 2.73 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 61 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 25 | No. of Aromatic Carbocycles | 0 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 36 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 21 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 0 |
| nHA | 4 | APOL | 62.2825 |
| nHD | 2 | BPOL | 38.7195 |
| QED | 0.244 |
| Synth | 3.211 |
| Natural Product Likeliness | 1.459 |
| NR-PPAR-gamma | 0.919 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0 |
| HIA | 0.057 |
| CACO-2 | -5.285 |
| MDCK | 0.000141761 |
| BBB | 0.178 |
| PPB | 0.971663 |
| VDSS | 0.892 |
| FU | 0.0165716 |
| CYP1A2-inh | 0.242 |
| CYP1A2-sub | 0.365 |
| CYP2c19-inh | 0.243 |
| CYP2c19-sub | 0.103 |
| CYP2c9-inh | 0.266 |
| CYP2c9-sub | 0.865 |
| CYP2d6-inh | 0.169 |
| CYP2d6-sub | 0.895 |
| CYP3a4-inh | 0.844 |
| CYP3a4-sub | 0.18 |
| CL | 5.203 |
| T12 | 0.959 |
| hERG | 0.221 |
| Ames | 0.85 |
| ROA | 0.008 |
| SkinSen | 0.95 |
| Carcinogencity | 0.678 |
| EI | 0.021 |
| Respiratory | 0.497 |
| NR-Aromatase | 0.526 |
| Antiviral | Yes |
| Prediction | 0.800973 |